Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page
- Check7 days agoChange DetectedThe Publications section now includes a new 2026 JAMA Oncology publication citation related to KEYNOTE-826, and the revision tag indicates version 3.7.0 (replacing the prior 3.6.6).SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.6.6 was added, and Plain Language Summary as well as Revision: v3.6.5 were removed from the page. This reflects an update to the page's revision history and the removal of a lay-friendly overview from the study record.SummaryDifference0.0%

- Check28 days agoChange Detected- The page now shows an explicit NIH grant/contract entry (2018) under Other Study ID Numbers, signaling a funding source for the trial.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded a new revision entry v3.6.5 and removed the previous v3.6.4 from the page history. This update records a minor administrative change to the page's version history with no impact on displayed content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor documentation/version bump; no study details or UI changes are indicated.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded a new publication citation detailing the final KEYNOTE-826 analysis (Ann Oncol, 2025). Updated the record version to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.